Includes bibliographical references (leaves 51-60)Chromosomal imbalances, in which there is a resulting loss or gain of genetic material, are found in 1 out of every 230 newborns and are cited as the most recognized cause of developmental delay and/or mental retardation in children with congenital anomalies. Array Comparative Genomic Hybridization (array CGH) can detect chromosomal imbalances, aiso known as genetic copy number changes, throughout the genome at a higher resolution than traditional cytogenetic methods. Since it has the potential to provide automated, comprehensive, and sensitive results, array CGH technology has been recently applied to the prenatal diagnostic field despite the lack of official guidelines governing its use. G...
To assess the feasibility of offering array-based comparative genomic hybridization testing for pren...
Objective: This study aims to evaluate the diagnostic yield of comparative genomic hybridization mic...
Array-based comparative genomic hybridization is a recently introduced technique for the detection o...
The mainstay for prenatal diagnosis of fetuses with abnormal ultrasound is karyotyping. Array compar...
Objective To evaluate the clinical value of prenatal array comparative genomic hybridisation (CGH) i...
The diagnostic benefits of array comparative genomic hybridisation (CGH) have been demonstrated, wit...
The study is conceived and designed with its goals to find out what elements matter most when people...
Array comparative genomic hybridisation (aCGH) represents a major advance in the field of cytogeneti...
Prenatal genetic diagnostic and screening tests have been rapidly evolving over the past decade with...
International audienceMicroarray-based comparative genomic hybridization (aCGH) is commonly used in ...
As the use of non-invasive prenatal testing becomes more ubiquitous during pregnancy, genetic counse...
Microarray-based comparative genomic hybridization (array CGH) is a newly emerged molecular cytogene...
Our aim was to construct a streamlined technical workflow to facilitate a prospective, multi-centre ...
Conventional karyotyping detects chromosomal anomalies in up to 35% of pregnancies with fetal ultras...
To assess the feasibility of offering array-based comparative genomic hybridization testing for pren...
Objective: This study aims to evaluate the diagnostic yield of comparative genomic hybridization mic...
Array-based comparative genomic hybridization is a recently introduced technique for the detection o...
The mainstay for prenatal diagnosis of fetuses with abnormal ultrasound is karyotyping. Array compar...
Objective To evaluate the clinical value of prenatal array comparative genomic hybridisation (CGH) i...
The diagnostic benefits of array comparative genomic hybridisation (CGH) have been demonstrated, wit...
The study is conceived and designed with its goals to find out what elements matter most when people...
Array comparative genomic hybridisation (aCGH) represents a major advance in the field of cytogeneti...
Prenatal genetic diagnostic and screening tests have been rapidly evolving over the past decade with...
International audienceMicroarray-based comparative genomic hybridization (aCGH) is commonly used in ...
As the use of non-invasive prenatal testing becomes more ubiquitous during pregnancy, genetic counse...
Microarray-based comparative genomic hybridization (array CGH) is a newly emerged molecular cytogene...
Our aim was to construct a streamlined technical workflow to facilitate a prospective, multi-centre ...
Conventional karyotyping detects chromosomal anomalies in up to 35% of pregnancies with fetal ultras...
To assess the feasibility of offering array-based comparative genomic hybridization testing for pren...
Objective: This study aims to evaluate the diagnostic yield of comparative genomic hybridization mic...
Array-based comparative genomic hybridization is a recently introduced technique for the detection o...